(Q45762661)

English

Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme

scientific article published on 20 January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme (English)

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

0 references

Thomas Benfield

3

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

Karen A. Krogfelt

7

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

Lotte Munch Lambertsen

8

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

Palle Valentiner-Branth

2

object named as

Palle Valentiner-Branth

1 reference

Europe PubMed Central

15 December 2017

author name string

Zitta B Harboe

1

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

Jens Jørgen Christensen

4

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

Peter H Andersen

5

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

Michael Howitz

6

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

Helle B Konradsen

9

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

language of work or name

0 references

publication date

20 January 2010

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

28

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

2642-2647

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

14

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

Pathogenesis and pathophysiology of pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Impact of conjugate pneumococcal vaccines on antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona Before and After Pediatric 7‐Valent Pneumococcal Conjugate Vaccine Introduction, 1997–2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

DECLINE IN PNEUMOCOCCAL MENINGITIS IN SPAIN AFTER INTRODUCTION OF THE HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

[Pneumococcal meningitis in children in France: 832 cases from 2001 to 2007]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Pneumococcal disease surveillance in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Six newly recognized types of Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.01.017

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/20096392

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45762661&oldid=2081385974"